Literature DB >> 25278577

Coagulase-negative staphylococci.

Karsten Becker1, Christine Heilmann2, Georg Peters2.   

Abstract

The definition of the heterogeneous group of coagulase-negative staphylococci (CoNS) is still based on diagnostic procedures that fulfill the clinical need to differentiate between Staphylococcus aureus and those staphylococci classified historically as being less or nonpathogenic. Due to patient- and procedure-related changes, CoNS now represent one of the major nosocomial pathogens, with S. epidermidis and S. haemolyticus being the most significant species. They account substantially for foreign body-related infections and infections in preterm newborns. While S. saprophyticus has been associated with acute urethritis, S. lugdunensis has a unique status, in some aspects resembling S. aureus in causing infectious endocarditis. In addition to CoNS found as food-associated saprophytes, many other CoNS species colonize the skin and mucous membranes of humans and animals and are less frequently involved in clinically manifested infections. This blurred gradation in terms of pathogenicity is reflected by species- and strain-specific virulence factors and the development of different host-defending strategies. Clearly, CoNS possess fewer virulence properties than S. aureus, with a respectively different disease spectrum. In this regard, host susceptibility is much more important. Therapeutically, CoNS are challenging due to the large proportion of methicillin-resistant strains and increasing numbers of isolates with less susceptibility to glycopeptides.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25278577      PMCID: PMC4187637          DOI: 10.1128/CMR.00109-13

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  611 in total

1.  Novel non-mecA-containing staphylococcal chromosomal cassette composite island containing pbp4 and tagF genes in a commensal staphylococcal species: a possible reservoir for antibiotic resistance islands in Staphylococcus aureus.

Authors:  Kanokporn Mongkolrattanothai; Susan Boyle; Trudy V Murphy; Robert S Daum
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Staphylococcus lugdunensis arthritis: a complication of arthroscopy.

Authors:  E Palazzo; J Pierre; N Besbes
Journal:  J Rheumatol       Date:  1992-02       Impact factor: 4.666

3.  Enterotoxin production by staphylococci isolated from foods in France.

Authors:  J P Rosec; J P Guiraud; C Dalet; N Richard
Journal:  Int J Food Microbiol       Date:  1997-04-15       Impact factor: 5.277

4.  Antibacterial activity of teichomycin, a new glycopeptide antibiotic, in comparison to vancomycin.

Authors:  G Peters; G Pulverer
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

5.  DNA methylase modifications and other linezolid resistance mutations in coagulase-negative staphylococci in Italy.

Authors:  Dafne Bongiorno; Floriana Campanile; Gino Mongelli; Maria Teresa Baldi; Rosamaria Provenzani; Silvia Reali; Carolina Lo Russo; Maria Santagati; Stefania Stefani
Journal:  J Antimicrob Chemother       Date:  2010-09-18       Impact factor: 5.790

6.  Predictive values of species' identifications from the Vitek Gram-Positive Identification Card using clinical isolates of coagulase-negative staphylococci.

Authors:  J A Kellogg; M D Hanna; S J Nelsen; L S Sprenkle; M L Thomas; K S Young
Journal:  Am J Clin Pathol       Date:  1996-09       Impact factor: 2.493

7.  Characterization of an extracellular metalloprotease with elastase activity from Staphylococcus epidermidis.

Authors:  P Teufel; F Götz
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

8.  Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.

Authors:  Silvia Natoli; Carla Fontana; Marco Favaro; Alberto Bergamini; Gian Piero Testore; Silvia Minelli; Maria Cristina Bossa; Mauro Casapulla; Giorgia Broglio; Angela Beltrame; Laura Cudillo; Raffaella Cerretti; Francesca Leonardis
Journal:  BMC Infect Dis       Date:  2009-06-04       Impact factor: 3.090

9.  Co-infection by two linezolid-resistant coagulase-negative staphylococci with two different resistance determinants.

Authors:  Annarita Mazzariol; Erika Kocsis; Luciana Bragagnolo; Giampietro Pellizzer; Mario Rassu; Giuseppe Cornaglia
Journal:  Scand J Infect Dis       Date:  2012-07-25

Review 10.  The emerging problem of linezolid-resistant Staphylococcus.

Authors:  Bing Gu; Theodoros Kelesidis; Sotirios Tsiodras; Janet Hindler; Romney M Humphries
Journal:  J Antimicrob Chemother       Date:  2012-09-04       Impact factor: 5.758

View more
  352 in total

1.  Septic Embolic Stroke Resulting From Staphylococcus lugdunensis Endocarditis.

Authors:  Htoo Kyaw; Atif Z Shaikh; Gokul Yaratha; Misra Deepika
Journal:  Ochsner J       Date:  2017

2.  Phenotypic and genotypic characterization of biofilm formation in Staphylococcus haemolyticus.

Authors:  Elaine M Barros; Moara Lemos; Thais Souto-Padrón; Marcia Giambiagi-deMarval
Journal:  Curr Microbiol       Date:  2015-02-28       Impact factor: 2.188

3.  Staphylococcus chromogenes, a Coagulase-Negative Staphylococcus Species That Can Clot Plasma.

Authors:  Danielle Cabral Dos Santos; Carla Christine Lange; Pedro Avellar-Costa; Katia Regina Netto Dos Santos; Maria Aparecida Vasconcelos Paiva Brito; Marcia Giambiagi-deMarval
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

4.  Development of a New Application for Comprehensive Viability Analysis Based on Microbiome Analysis by Next-Generation Sequencing: Insights into Staphylococcal Carriage in Human Nasal Cavities.

Authors:  Yu Jie Lu; Takashi Sasaki; Kyoko Kuwahara-Arai; Yuki Uehara; Keiichi Hiramatsu
Journal:  Appl Environ Microbiol       Date:  2018-05-17       Impact factor: 4.792

5.  Clinical significance of coagulase-negative staphylococci other than S. epidermidis blood stream isolates at a tertiary care hospital.

Authors:  Florian Hitzenbichler; Michaela Simon; Bernd Salzberger; Frank Hanses
Journal:  Infection       Date:  2016-09-22       Impact factor: 3.553

6.  Common variable immunodeficiency presenting in a man with recurrent pneumonia caused by Staphylococcus lugdunensis.

Authors:  Nkechi Chiugo Mbaebie; Sylvia Vania Alarcon Velasco; Jason Touhey
Journal:  BMJ Case Rep       Date:  2018-03-20

7.  The epidemiology of hospital-acquired urinary tract-related bloodstream infection in veterans.

Authors:  Payal K Patel; M Todd Greene; Mary A M Rogers; David Ratz; Latoya Kuhn; Jennifer Davis; Sanjay Saint
Journal:  Am J Infect Control       Date:  2018-03-13       Impact factor: 2.918

8.  Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis.

Authors:  M Carugati; C A Petti; C Arnold; J M Miro; J M Pericàs; C Garcia de la Maria; Z Kanafani; E Durante-Mangoni; J Baddley; D Wray; J L Klein; F Delahaye; N Fernandez-Hidalgo; M M Hannan; D Murdoch; A Bayer; V H Chu
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

9.  Identification and Characterization of Staphylococcus delphini Internalization Pathway in Nonprofessional Phagocytic Cells.

Authors:  Frederic Laurent; Sophie Trouillet-Assant; Yousef Maali; Alan Diot; Patrícia Martins-Simões; Michele Bes; Daniel Bouvard; François Vandenesch; Paul O Verhoeven
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.441

10.  Detection of mecA- and mecC-Positive Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates by the New Xpert MRSA Gen 3 PCR Assay.

Authors:  Karsten Becker; Olivier Denis; Sandrine Roisin; Alexander Mellmann; Evgeny A Idelevich; Dennis Knaack; Sarah van Alen; André Kriegeskorte; Robin Köck; Frieder Schaumburg; Georg Peters; Britta Ballhausen
Journal:  J Clin Microbiol       Date:  2015-10-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.